Keyword Connections

relapsing-remitting multiple sclerosis

Journals

3

1 Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology

2 therapeutic advances in neurological disorders

3 Journal of the neurological sciences

Research Groups

0

No Research Group Connected

Bibliographies

21

1 Reasons to switch: a noninterventional study evaluating immunotherapy switches in a large German multicentre cohort of patients with relapsing-remitting multiple sclerosis.

2 Fingolimod for the treatment of multiple sclerosis in French West Indies, a real-world study in patients from African ancestry.

3 Safety outcomes of disease-modifying therapies for relapsing-remitting multiple sclerosis: A network meta-analysis.

4 Clinical relevance of circadian melatonin release in relapsing-remitting multiple sclerosis.

5 Caregiver strain among life partners of persons with mild disability due to relapsing-remitting multiple sclerosis

6 Longitudinal cortical network reorganization in early relapsing-remitting multiple sclerosis.

7 GPU accelerated analysis of treg-teff cross regulation in relapsing-remitting multiple sclerosis

8 Pegylated versus non-pegylated interferon beta 1a in patients with relapsing-remitting multiple sclerosis: A cost-effectiveness analysis.

9 Altered intestinal permeability in patients with relapsing-remitting multiple sclerosis: A pilot study.

10 Cost-Effectiveness of Natalizumab Compared With Fingolimod for Relapsing-Remitting Multiple Sclerosis Treatment in Colombia.

11 Peripheral CD39-expressing T regulatory cells are increased and associated with relapsing-remitting multiple sclerosis in relapsing patients

12 Peripheral CD39-expressing T regulatory cells are increased and associated with relapsing-remitting multiple sclerosis in relapsing patients

13 IL-17A is associated with the breakdown of the blood-brain barrier in relapsing-remitting multiple sclerosis.

14 impact of natalizumab treatment on fatigue, mood and aspects of cognition in relapsing-remitting multiple sclerosis

15 determination of soluble icam-1 and tnfalphar in the cerebrospinal fluid and serum levels in a population of brazilian patients with relapsing-remitting multiple sclerosis determinação dos níveis de icam-1 e tnfalfar solúvel no líquido cefalorraqueano e soro numa população de pacientes brasileiros com esclerose múltipla forma surto-remissão

16 repopulation of t, b, and nk cells following alemtuzumab treatment in relapsing-remitting multiple sclerosis

17 fluctuations of spontaneous eeg topographies predict disease state in relapsing-remitting multiple sclerosis

18 the outbreak fingolimod cardiovascular side effects in relapsing-remitting multiple sclerosis patient: a longitudinal study in an iranian population

19 effects of adjunct low-dose vitamin d on relapsing-remitting multiple sclerosis progression: preliminary findings of a randomized placebo-controlled trial

20 short-term mri measurements as predictors of edss progression in relapsing-remitting multiple sclerosis: grey matter atrophy but not lesions are predictive in a real-life setting

21 Olfactory Dysfunction and Cognition in Radiologically Isolated Syndrome and Relapsing-Remitting Multiple Sclerosis.